78 related articles for article (PubMed ID: 2071895)
21. A cluster of positively charged amino acids in the alpha-chain of C4b-binding protein (C4BP) is pivotal for the regulation of the complement system and the interaction with bacteria.
Blom AM
Scand J Clin Lab Invest Suppl; 2000; 233():37-49. PubMed ID: 11317941
[TBL] [Abstract][Full Text] [Related]
22. The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.
Krishnan V; Xu Y; Macon K; Volanakis JE; Narayana SV
Acta Crystallogr D Biol Crystallogr; 2009 Mar; 65(Pt 3):266-74. PubMed ID: 19237749
[TBL] [Abstract][Full Text] [Related]
23. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
Kozlov LV; Shibanova ED; Zinchenko AA
Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
[TBL] [Abstract][Full Text] [Related]
24. Third component of trout complement. cDNA cloning and conservation of functional sites.
Lambris JD; Lao Z; Pang J; Alsenz J
J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
[TBL] [Abstract][Full Text] [Related]
25. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1982 Dec; 129(6):2603-7. PubMed ID: 6923908
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of secretion of human complement component C2 by the product of an alternatively spliced C2 messenger RNA.
Tsukamoto H; Tousson A; Marchase RB; Volanakis JE
J Immunol; 1996 Jun; 156(12):4901-8. PubMed ID: 8648140
[TBL] [Abstract][Full Text] [Related]
27. Cysteine-scanning mutagenesis of helix IV and the adjoining loops in the lactose permease of Escherichia coli: Glu126 and Arg144 are essential. off.
Frillingos S; Gonzalez A; Kaback HR
Biochemistry; 1997 Nov; 36(47):14284-90. PubMed ID: 9400367
[TBL] [Abstract][Full Text] [Related]
28. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
29. Murine C4b-binding protein. Mapping of the ligand binding site and the N-terminus of the pre-protein.
Ogata RT; Mathias P; Bradt BM; Cooper NR
J Immunol; 1993 Mar; 150(6):2273-80. PubMed ID: 8450212
[TBL] [Abstract][Full Text] [Related]
30. The role of transmembrane domain III in the lactose permease of Escherichia coli.
Sahin-Tóth M; Frillingos S; Bibi E; Gonzalez A; Kaback HR
Protein Sci; 1994 Dec; 3(12):2302-10. PubMed ID: 7756986
[TBL] [Abstract][Full Text] [Related]
31. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
Harris JM; McIntosh EM; Muscat GE
J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
[TBL] [Abstract][Full Text] [Related]
32. A Schistosoma protein, Sh-TOR, is a novel inhibitor of complement which binds human C2.
Inal JM; Sim RB
FEBS Lett; 2000 Mar; 470(2):131-4. PubMed ID: 10734221
[TBL] [Abstract][Full Text] [Related]
33. The purification and properties of the second component of guinea-pig complement.
Kerr MA; Gagnon J
Biochem J; 1982 Jul; 205(1):59-67. PubMed ID: 6922702
[TBL] [Abstract][Full Text] [Related]
34. Two clusters of acidic amino acids near the NH2 terminus of complement component C4 alpha'-chain are important for C2 binding.
Pan Q; Ebanks RO; Isenman DE
J Immunol; 2000 Sep; 165(5):2518-27. PubMed ID: 10946278
[TBL] [Abstract][Full Text] [Related]
35. Human complement factor B: cDNA cloning, nucleotide sequencing, phenotypic conversion by site-directed mutagenesis and expression.
Horiuchi T; Kim S; Matsumoto M; Watanabe I; Fujita S; Volanakis JE
Mol Immunol; 1993 Dec; 30(17):1587-92. PubMed ID: 8247029
[TBL] [Abstract][Full Text] [Related]
36. Cleavage of C2 by C1s into the antigenically distinct fragments C2a and C2b: demonstration of binding of C2b to C4b.
Nagasawa S; Stroud RM
Proc Natl Acad Sci U S A; 1977 Jul; 74(7):2998-3001. PubMed ID: 70787
[TBL] [Abstract][Full Text] [Related]
37. A corresponding tyrosine residue in the C2/factor B type A domain is a hot spot in the decay acceleration of the complement C3 convertases.
Kuttner-Kondo LA; Dybvig MP; Mitchell LM; Muqim N; Atkinson JP; Medof ME; Hourcade DE
J Biol Chem; 2003 Dec; 278(52):52386-91. PubMed ID: 14561755
[TBL] [Abstract][Full Text] [Related]
38. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.
Carroll MC; Fathallah DM; Bergamaschini L; Alicot EM; Isenman DE
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6868-72. PubMed ID: 2395880
[TBL] [Abstract][Full Text] [Related]
39. Hemolytically inactive C4B complement allotype caused by a proline to leucine mutation in the C5-binding site.
McLean RH; Niblack G; Julian B; Wang T; Wyatt R; Phillips JA; Collins TS; Winkelstein J; Valle D
J Biol Chem; 1994 Nov; 269(44):27727-31. PubMed ID: 7961694
[TBL] [Abstract][Full Text] [Related]
40. The second component of human complement: use of glycosidases and glucosylation to distinguish the two forms.
Schultz DR; Loos M
Immunobiology; 1988 Mar; 176(4-5):394-409. PubMed ID: 3391637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
